Nishinomiya, Japan

W Ewan Hume

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: W Ewan Hume. Retrieved from https://idiyas.com/inventor/w-ewan-hume

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: W Ewan Hume: Innovator in Pharmaceutical Chemistry

Introduction

W Ewan Hume is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly with his work on oxindole derivatives. His innovative approach has led to the development of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

W Ewan Hume holds a patent for an oxindole derivative. This invention is crucial in the pharmaceutical industry, as it may lead to the development of new therapeutic agents. His patent portfolio reflects his commitment to innovation and the enhancement of drug development processes.

Career Highlights

Hume is currently employed at Sumitomo Pharmaceuticals Company Limited, where he continues to contribute to groundbreaking research and development. His work at this esteemed company has positioned him as a key player in the pharmaceutical sector, driving forward the boundaries of what is possible in medicine.

Collaborations

Throughout his career, W Ewan Hume has collaborated with talented individuals such as Takashi Umezome and Ryu Nagata. These partnerships have fostered a creative environment that encourages the exchange of ideas and the pursuit of innovative solutions in pharmaceutical research.

Conclusion

W Ewan Hume is a distinguished inventor whose work in pharmaceutical chemistry has made a lasting impact. His patent on oxindole derivatives exemplifies his innovative spirit and dedication to improving healthcare. Through his career at Sumitomo Pharmaceuticals Company Limited and collaborations with esteemed colleagues, Hume continues to shape the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…